Table 2. This table displays the percentage of patients who reported resolution of specific long COVID-19 symptoms following stellate ganglion block treatment.
Symptom | Total reports | All relief (%) | Males (relief %) | Females (relief %) |
Shortness of breath | 17 | 88 | 80 | 100 |
Cough | 10 | 80 | 80 | 67 |
Fatigue | 35 | 77 | 67 | 85 |
Chest pain | 10 | 80 | 50 | 100 |
Joint pain | 16 | 94 | 86 | 100 |
Tachycardia/palpitations | 9 | 78 | 50 | 100 |
Symptoms worsen | 27 | 74 | 64 | 92 |
Pins and needles | 9 | 100 | 100 | 100 |
Diarrhea | 8 | 88 | 67 | 100 |
Changes in taste/smell | 18 | 56 | 40 | 75 |
Fever | 1 | 100 | - | 100 |
Dizziness | 17 | 77 | 64 | 100 |
Difficulty sleeping | 14 | 71 | 57 | 86 |
Rash | 2 | 100 | - | 100 |
Mood changes | 21 | 76 | 64 | 90 |
Headache | 16 | 81 | 63 | 100 |
Changes in menstrual cycle | 5 | 80 | - | 80 |
Brain fog | 33 | 79 | 60 | 94 |